Superinfection with a heterologous HIV strain per se does not lead to faster progression

Mathematical Biosciences

Volumn 224, Issue 1, 2010, Pages 1-9

  Fung, Isaac Chun Hai ^a   Gambhir, Manoj ^a   van Sighem, Ard ^b   de Wolf, Frank ^a,b   Garnett, Geoffrey P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

AIDS; Immunology; Mathematical model; Public health; Virology

Indexed keywords

AIDS; CO-EXISTENCE; IMMUNE CELLS; PUBLIC HEALTH; RISKS OF EXPOSURE; SUPERINFECTION;

COMPUTER SIMULATION; DISEASES; HEALTH; HEALTH RISKS; IMMUNOLOGY; MICROBIOLOGY; STRAIN; VIRUSES;

MATHEMATICAL MODELS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; NUMERICAL MODEL; PUBLIC HEALTH; STOCHASTICITY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; HETEROLOGOUS EXPRESSION; HOST SUSCEPTIBILITY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; INFECTION SENSITIVITY; LYMPHOCYTE ACTIVATION; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MIXED INFECTION; NONHUMAN; QUANTITATIVE STUDY; QUASI EXPERIMENTAL STUDY; STOCHASTIC MODEL; STRAIN DIFFERENCE; SUPERINFECTION; VIRUS EXAMINATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALGORITHMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPUTER SIMULATION; DISEASE PROGRESSION; GENETIC FITNESS; HIV INFECTIONS; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOCYTE ACTIVATION; MODELS, BIOLOGICAL; STOCHASTIC PROCESSES; SUPERINFECTION; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 75549085402     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2009.11.007     Document Type: Article

References (59)

1. Smith D.M., Richman D.D., Little S.J. HIV superinfection. J. Infect. Dis. 2005, 192:438.
2. Blackard J.T., Cohen D.E., Mayer K.H. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clin. Infect. Dis. 2002, 34:1108.
3. Fultz P.N. HIV-1 superinfections: omens for vaccine efficacy?. AIDS 2004, 18:115.
4. Smith D.M., Strain M.C., Frost S.D., Pillai S.K., Wong J.K., Wrin T., Liu Y., Petropolous C.J., Daar E.S., Little S.J., Richman D.D. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology 2006, 355:1.
5. van der Kuyl A.C., Cornelissen M. Identifying HIV-1 dual infections. Retrovirology 2007, 4:67.
6. Jost S., Bernard M.C., Kaiser L., Yerly S., Hirschel B., Samri A., Autran B., Goh L.E., Perrin L. A patient with HIV-1 superinfection. N. Engl. J. Med. 2002, 347:731.
7. Gottlieb G.S., Nickle D.C., Jensen M.A., Wong K.G., Grobler J., Li F., Liu S.L., Rademeyer C., Learn G.H., Karim S.S., Williamson C., Corey L., Margolick J.B., Mullins J.I. Dual HIV-1 infection associated with rapid disease progression. Lancet 2004, 363:619.
8. Casado C., Pernas M., Alvaro T., Sandonis V., Garcia S., Rodriguez C., del Romero J., Grau E., Ruiz L., Lopez-Galindez C. Coinfection and superinfection in patients with long-term, nonprogressive HIV-1 disease. J. Infect. Dis. 2007, 196:895.
9. Lamine A., Caumont-Sarcos A., Chaix M.L., Saez-Cirion A., Rouzioux C., Delfraissy J.F., Pancino G., Lambotte O. Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study). AIDS 2007, 21:1043.
10. Blackard J.T., Mayer K.H. HIV superinfection in the era of increased sexual risk-taking. Sex. Transm. Dis. 2004, 31:201.
11. Brenner B., Routy J.P., Quan Y., Moisi D., Oliveira M., Turner D., Wainberg M.A. Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection. AIDS 2004, 18:1653.
12. Smith D.M., Wong J.K., Hightower G.K., Ignacio C.C., Koelsch K.K., Petropoulos C.J., Richman D.D., Little S.J. HIV drug resistance acquired through superinfection. AIDS 2005, 19:1251.
13. Hecht F.M., Wolf L.E., Lo B. Lessons from an HIV transmission pair. J. Infect. Dis. 2007, 195:1239.
14. Blick G., Kagan R.M., Coakley E., Petropoulos C., Maroldo L., Greiger-Zanlungo P., Gretz S., Garton T. The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient. J. Infect. Dis. 2007, 195:1250.
15. Piguet V., Gu F., Foti M., Demaurex N., Gruenberg J., Carpentier J.L., Trono D. Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 1999, 97:63.
16. Wildum S., Schindler M., Munch J., Kirchhoff F. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J. Virol. 2006, 80:8047.
17. Jung A., Maier R., Vartanian J.P., Bocharov G., Jung V., Fischer U., Meese E., Wain-Hobson S., Meyerhans A. Recombination - multiply infected spleen cells in HIV patients. Nature 2002, 418:144.
18. Dang Q., Chen J.B., Unutmaz D., Coffin J.M., Pathak V.K., Powell D., KewalRamani V.N., Maldarelli F., Hu W.S. Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. Proc. Natl. Acad. Sci. USA 2004, 101:632.
19. Chen J.B., Dang Q., Unutmaz D., Pathak V.K., Maldarelli F., Powell D., Hu W.S. Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: Preference in virus entry is important but is not the sole factor. J. Virol. 2005, 79:4140.
20. Levy D.N., Aldrovandi G.M., Kutsch O., Shaw G.M. Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. USA 2004, 101:4204.
21. D.N. Levy, G.M. Aldrovandi, O. Kutsch, G.M. Shaw, Dynamics of HIV-1 recombination in its natural target cells (vol. 101, 2004, p. 4204). Proc. Natl. Acad. Sci. USA 102 (2005) 1808-1808.
22. Nethe M., Berkhout B., van der Kuyl A.C. Retroviral superinfection resistance. Retrovirology 2005, 2:52.
23. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., Ho D.D. HIV-1 dynamics in vivo: virion clearance, rate infected cell life-span, and viral generation time. Science 1996, 271:1582.
24. Perelson A.S., Nelson P.W. Mathematical analysis of HIV-1 dynamics in vivo. SIAM Rev. 1999, 41:3.
25. Nowak M.A., May R.M. Virus Dynamics: Mathematical Principles of Immunology and Virology 2000, Oxford University, Oxford.
26. Ferguson N.M., de Wolf F., Ghani A.C., Fraser C., Donnelly C.A., Reiss P., Lange J.M., Danner S.A., Garnett G.P., Goudsmit J., Anderson R.M. Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 1999, 96:15167.
27. Kim H.J., Perelson A.S. Viral and latent reservoir persistence in HIV-1-infected patients on therapy. PLoS Comput. Biol. 2006, 2:1232.
28. Jones L.E., Perelson A.S. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART. Bull. Math. Biol. 2005, 67:1227.
29. Jones L.E., Perelson A.S. Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2007, 45:483.
30. Fraser C., Ferguson N.M., de Wolf F., Anderson R.M. The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications. Proc. Biol. Sci. 2001, 268:2085.
31. Griffin J.T., Fraser C., Gras L., de Wolf F., Ghani A.C. The effect on treatment comparisons of different measurement frequencies in human immunodeficiency virus observational databases. Am. J. Epidemiol. 2006, 163:676.
32. Fraser C., Ferguson N.M., Anderson R.M. Quantification of intrinsic residual viral replication in treated HIV-infected patients. Proc. Natl. Acad. Sci. USA 2001, 98:15167.
33. Asquith B., Edwards C.T., Lipsitch M., McLean A.R. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol. 2006, 4:e90.
34. Altfeld M., Allen T.M., Yu X.G., Johnston M.N., Agrawal D., Korber B.T., Montefiori D.C., O'Connor D.H., Davis B.T., Lee P.K., Maier E.L., Harlow J., Goulder P.J., Brander C., Rosenberg E.S., Walker B.D. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 2002, 420:434.
35. Plantier J.C., Lemee V., Dorval I., Gueudin M., Braun J., Hutin P., Ruffault A., Simon F. HIV-1 group M superinfection in an HIV-1 group O-infected patient. AIDS 2004, 18:2444.
36. Chohan B., Lavreys L., Rainwater S.M., Overbaugh J. Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype. J. Virol. 2005, 79:10701.
37. Manigart O., Courgnaud V., Sanou O., Valea D., Nagot N., Meda N., Delaporte E., Peeters M., Van de Perre P. HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso as assessed by an autologous heteroduplex mobility procedure. AIDS 2004, 18:1645.
38. Ramos A., Hu D.J., Nguyen L., Phan K.O., Vanichseni S., Promadej N., Choopanya K., Callahan M., Young N.L., McNicholl J., Mastro T.D., Folks T.M., Subbarao S. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J. Virol. 2002, 76:7444.
39. van der Kuyl A.C., Kozaczynska K., van den Burg R., Zorgdrager F., Back N., Jurriaans S., Berkhout B., Reiss P., Cornelissen M. Triple HIV-1 infection. N. Engl. J. Med. 2005, 352:2557.
40. Jurriaans S., Kozaczynska K., Zorgdrager F., Steingrover R., Prins J.M., van der Kuyl A.C., Cornelissen M. A sudden rise in viral load is infrequently associated with HIV-1 superinfection. J. Acquir. Immune Defic. Syndr. 2008, 47:69.
41. Piantadosi A., Chohan B., Chohan V., McClelland R.S., Overbaugh J. Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog. 2007, 3:e177.
42. Koelsch K.K., Smith D.M., Little S.J., Ignacio C.C., Macaranas T.R., Brown A.J., Petropoulos C.J., Richman D.D., Wong J.K. Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus. AIDS 2003, 17:F11.
43. Gottlieb G.S., Nickle D.C., Jensen M.A., Wong K.G., Kaslow R.A., Shepherd J.C., Margolick J.B., Mullins J.I. HIV type 1 superinfection with a dual-tropic virus and rapid progression to AIDS: a case report. Clin. Infect. Dis. 2007, 45:501.
44. Yerly S., Jost S., Monnat M., Telenti A., Cavassini M., Chave J.P., Kaiser L., Burgisser P., Perrin L. HIV-1 co/super-infection in intravenous drug users. AIDS 2004, 18:1413.
45. Yang O.O., Daar E.S., Jamieson B.D., Balamurugan A., Smith D.M., Pitt J.A., Petropoulos C.J., Richman D.D., Little S.J., Brown A.J. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J. Virol. 2005, 79:860.
46. McCutchan F.E., Hoelscher M., Tovanabutra S., Piyasirisilp S., Sanders-Buell E., Ramos G., Jagodzinski L., Polonis V., Maboko L., Mmbando D., Hoffmann O., Riedner G., von Sonnenburg F., Robb M., Birx D.L. In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation and intercompartment dynamics from the seronegative window period through 30 months postinfection. J. Virol. 2005, 79:11693.
47. Pernas M., Casado C., Fuentes R., Perez-Elias M.J., Lopez-Galindez C. A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. J. Acquir. Immune Defic. Syndr. 2006, 42:12.
48. Dixit N.M., Perelson A.S. Multiplicity of human immunodeficiency virus infections in lymphoid tissue. J. Virol. 2004, 78:8942.
49. Dixit N.M., Perelson A.S. HIV dynamics with multiple infections of target cells. Proc. Natl. Acad. Sci. USA 2005, 102:8198.
50. Suryavanshi G.W., Dixit N.M. Emergence of recombinant forms of HIV: Dynamics and scaling. PLoS Comput. Biol. 2007, 3:2003.
51. Chakraborty B., Kiser P., Rangel H.R., Weber J., Mirza M., Marotta M.L., Asaad R., Rodriguez B., Valdez H., Lederman M.M., Quinones-Mateu M.E. Can HIV-1 superinfection compromise antiretroviral therapy?. AIDS 2004, 18:132.
52. Smith D.M., Wong J.K., Hightower G.K., Ignacio C.C., Koelsch K.K., Daar E.S., Richman D.D., Little S.J. Incidence of HIV superinfection following primary infection. JAMA 2004, 292:1177.
53. Fang G., Weiser B., Kuiken C., Philpott S.M., Rowland-Jones S., Plummer F., Kimani J., Shi B., Kaul R., Bwayo J., Anzala O., Burger H. Recombination following superinfection by HIV-1. AIDS 2004, 18:153.
54. Rouzine I.M., Sergeev R.A., Glushtsov A.I. Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 2006, 103:666.
55. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action, Time from HIV-1 seroconversion to AIDS and death before widespread use of highly active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action Concerted Action. on SeroConversion to AIDS and Death in Europe, Lancet 355 (2000) 1131-1137.
56. Hellerstein M., Hanley M.B., Cesar D., Siler S., Papageorgopoulos C., Wieder E., Schmidt D., Hoh R., Neese R., Macallan D., Deeks S., McCune J.M. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 1999, 5:83.
57. Klenerman P., Phillips R.E., Rinaldo C.R., Wahl L.M., Ogg G., May R.M., McMichael A.J., Nowak M.A. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc. Natl. Acad. Sci. USA 1996, 93:15323.
58. Ogg G.S., Jin X., Bonhoeffer S., Dunbar P.R., Nowak M.A., Monard S., Segal J.P., Cao Y.Z., Rowland-Jones S.L., Cerundolo V., Hurley A., Markowitz M., Ho D.D., Nixon D.F., McMichael A.J. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998, 279:2103.
59. McKay M.D., Latin hypercube sampling as a tool in uncertainty analysis of computer models, in: 1992 Winter Simulation Conference Proceedings, 1992, pp. 557-564.